(+)-catechin multiple interactions ISO RGD:1309044 6480464 Catechin inhibits the reaction [Dietary Fats results in decreased expression of PNPLA2 mRNA] CTD PMID:23365609 (-)-cotinine multiple interactions ISO RGD:1309044 6480464 [Nicotine results in increased abundance of Cotinine] which results in increased expression of PNPLA2 mRNA, [Nicotine results in increased abundance of Cotinine] which results in increased expression of PNPLA2 protein CTD PMID:29617909 (-)-epigallocatechin 3-gallate multiple interactions ISO RGD:1354502 6480464 [potassium chromate(VI) co-treated with epigallocatechin gallate] results in increased expression of PNPLA2 mRNA CTD PMID:22079256 (1->4)-beta-D-glucan multiple interactions EXP 6480464 [perfluorooctane sulfonic acid co-treated with Cellulose] results in increased expression of PNPLA2 mRNA CTD PMID:36331819 (S)-nicotine decreases expression ISO RGD:1309044 6480464 Nicotine results in decreased expression of PNPLA2 mRNA CTD PMID:29155039 (S)-nicotine multiple interactions ISO RGD:1309044 6480464 [Nicotine results in increased abundance of Cotinine] which results in increased expression of PNPLA2 mRNA, [Nicotine results in increased abundance of Cotinine] which results in increased expression of PNPLA2 protein CTD PMID:29617909 1,2-dimethylhydrazine affects expression EXP 6480464 1, 2-Dimethylhydrazine affects the expression of PNPLA2 mRNA CTD PMID:22206623 17alpha-ethynylestradiol increases expression EXP 6480464 Ethinyl Estradiol results in increased expression of PNPLA2 mRNA CTD PMID:17942748 17alpha-ethynylestradiol decreases expression ISO RGD:1309044 6480464 Ethinyl Estradiol results in decreased expression of PNPLA2 mRNA CTD PMID:17557909 17alpha-ethynylestradiol multiple interactions EXP 6480464 [Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in decreased expression of PNPLA2 mRNA CTD PMID:17942748 17alpha-ethynylestradiol affects expression EXP 6480464 Ethinyl Estradiol affects the expression of PNPLA2 mRNA CTD PMID:17555576 17beta-estradiol affects expression ISO RGD:1354502 6480464 Estradiol affects the expression of PNPLA2 mRNA CTD PMID:22574217 17beta-estradiol increases expression EXP 6480464 Estradiol results in increased expression of PNPLA2 mRNA CTD PMID:28476547 17beta-estradiol multiple interactions EXP 6480464 bisphenol A promotes the reaction [Estradiol results in increased expression of PNPLA2 mRNA] CTD PMID:28476547 2,2',4,4',5,5'-hexachlorobiphenyl multiple interactions EXP 6480464 [Dietary Sucrose co-treated with Dietary Fats co-treated with bisphenol A co-treated with Diethylhexyl Phthalate co-treated with Tetrachlorodibenzodioxin co-treated with 2 more ... CTD PMID:28433925 , PMID:30722647 2,3,7,8-tetrachlorodibenzodioxine multiple interactions EXP 6480464 [Dietary Sucrose co-treated with Dietary Fats co-treated with bisphenol A co-treated with Diethylhexyl Phthalate co-treated with Tetrachlorodibenzodioxin co-treated with 2 more ... CTD PMID:17942748 more ... 2,3,7,8-tetrachlorodibenzodioxine increases expression EXP 6480464 Tetrachlorodibenzodioxin results in increased expression of PNPLA2 mRNA CTD PMID:28238261 2,3,7,8-tetrachlorodibenzodioxine affects expression EXP 6480464 Tetrachlorodibenzodioxin affects the expression of PNPLA2 mRNA CTD PMID:21570461 , PMID:24680724 2,3,7,8-tetrachlorodibenzodioxine decreases expression ISO RGD:1309044 6480464 Tetrachlorodibenzodioxin results in decreased expression of PNPLA2 mRNA CTD PMID:21215274 2,3,7,8-tetrachlorodibenzodioxine affects expression ISO RGD:1309044 6480464 Tetrachlorodibenzodioxin affects the expression of PNPLA2 mRNA CTD PMID:22298810 2,4-dinitrotoluene affects expression ISO RGD:1309044 6480464 2, 4-dinitrotoluene affects the expression of PNPLA2 mRNA CTD PMID:21346803 2,6-dinitrotoluene affects expression ISO RGD:1309044 6480464 2, 6-dinitrotoluene affects the expression of PNPLA2 mRNA CTD PMID:21346803 3,3',4,4'-tetrachlorobiphenyl multiple interactions EXP 6480464 3 more ... CTD PMID:19467301 3,3',5-triiodo-L-thyronine decreases phosphorylation EXP 6480464 Triiodothyronine results in decreased phosphorylation of PNPLA2 protein CTD PMID:30209975 3,3',5-triiodo-L-thyronine increases expression EXP 6480464 Triiodothyronine results in increased expression of PNPLA2 mRNA CTD PMID:30209975 3,4-methylenedioxymethamphetamine increases expression EXP 6480464 N-Methyl-3, 4-methylenedioxyamphetamine results in increased expression of PNPLA2 mRNA CTD PMID:26251327 3-isobutyl-1-methyl-7H-xanthine multiple interactions ISO RGD:1354502 6480464 [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin] results in increased expression of PNPLA2 mRNA CTD PMID:28628672 3-isobutyl-1-methyl-7H-xanthine multiple interactions EXP 6480464 [Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS1 protein] results in increased expression of PNPLA2 mRNA more ... CTD PMID:29288687 , PMID:34302803 4,4'-sulfonyldiphenol increases expression ISO RGD:1354502 6480464 bis(4-hydroxyphenyl)sulfone results in increased expression of PNPLA2 protein CTD PMID:34186270 4-hydroxyphenyl retinamide decreases expression EXP 6480464 Fenretinide results in decreased expression of PNPLA2 mRNA CTD PMID:28973697 6-propyl-2-thiouracil decreases expression ISO RGD:1309044 6480464 Propylthiouracil results in decreased expression of PNPLA2 mRNA CTD PMID:24780913 , PMID:25825206 aldehydo-D-glucose decreases expression ISO RGD:1354502 6480464 Glucose deficiency results in decreased expression of PNPLA2 protein CTD PMID:24802182 aldrin decreases expression EXP 6480464 Aldrin results in decreased expression of PNPLA2 mRNA CTD PMID:18579281 amphetamine increases expression ISO RGD:1309044 6480464 Amphetamine results in increased expression of PNPLA2 mRNA CTD PMID:30779732 aristolochic acid A increases expression ISO RGD:1354502 6480464 aristolochic acid I results in increased expression of PNPLA2 mRNA CTD PMID:33212167 atrazine increases expression ISO RGD:1354502 6480464 Atrazine results in increased expression of PNPLA2 mRNA CTD PMID:22378314 benzalkonium chloride decreases expression EXP 6480464 Benzalkonium Compounds results in decreased expression of PNPLA2 mRNA CTD PMID:31199489 benzo[a]pyrene decreases expression ISO RGD:1354502 6480464 Benzo(a)pyrene results in decreased expression of PNPLA2 mRNA CTD PMID:20106945 benzo[a]pyrene decreases methylation ISO RGD:1354502 6480464 Benzo(a)pyrene results in decreased methylation of PNPLA2 exon, Benzo(a)pyrene results in decreased methylation of PNPLA2 promoter CTD PMID:27901495 benzo[a]pyrene decreases expression EXP 6480464 Benzo(a)pyrene results in decreased expression of PNPLA2 mRNA CTD PMID:23735875 benzo[a]pyrene increases expression EXP 6480464 Benzo(a)pyrene results in increased expression of PNPLA2 mRNA CTD PMID:21569818 benzo[a]pyrene diol epoxide I increases expression ISO RGD:1354502 6480464 7 more ... CTD PMID:19150397 bis(2-ethylhexyl) phthalate increases expression ISO RGD:1309044 6480464 Diethylhexyl Phthalate results in increased expression of PNPLA2 mRNA CTD PMID:22672789 bis(2-ethylhexyl) phthalate multiple interactions EXP 6480464 [Dietary Sucrose co-treated with Dietary Fats co-treated with bisphenol A co-treated with Diethylhexyl Phthalate co-treated with Tetrachlorodibenzodioxin co-treated with 2 more ... CTD PMID:28433925 , PMID:30722647 bisphenol A increases expression EXP 6480464 bisphenol A results in increased expression of PNPLA2 mRNA CTD PMID:26944108 , PMID:35504408 bisphenol A increases expression ISO RGD:1354502 6480464 bisphenol A results in increased expression of PNPLA2 protein CTD PMID:34186270 bisphenol A decreases methylation ISO RGD:1309044 6480464 bisphenol A results in decreased methylation of PNPLA2 gene CTD PMID:35504408 bisphenol A increases expression ISO RGD:1309044 6480464 bisphenol A results in increased expression of PNPLA2 mRNA CTD PMID:34947998 , PMID:35504408 bisphenol A multiple interactions ISO RGD:1309044 6480464 bisphenol A promotes the reaction [Fructose results in decreased expression of PNPLA2 mRNA] more ... CTD PMID:31661889 , PMID:34165232 bisphenol A decreases expression ISO RGD:1309044 6480464 bisphenol A results in decreased expression of PNPLA2 mRNA, bisphenol A results in decreased expression of PNPLA2 protein CTD PMID:27806752 more ... bisphenol A decreases methylation EXP 6480464 bisphenol A results in decreased methylation of PNPLA2 gene, bisphenol A results in decreased methylation of PNPLA2 promoter CTD PMID:27312807 , PMID:35504408 bisphenol A multiple interactions EXP 6480464 [Dietary Sucrose co-treated with Dietary Fats co-treated with bisphenol A co-treated with Diethylhexyl Phthalate co-treated with Tetrachlorodibenzodioxin co-treated with 2 more ... CTD PMID:28433925 more ... bisphenol A decreases expression EXP 6480464 bisphenol A results in decreased expression of PNPLA2 mRNA CTD PMID:28500084 Bisphenol A diglycidyl ether multiple interactions EXP 6480464 2, 2-bis(4-glycidyloxyphenyl)propane inhibits the reaction [rosiglitazone results in increased expression of PNPLA2 mRNA] CTD PMID:18643838 Bisphenol B increases expression ISO RGD:1354502 6480464 bisphenol B results in increased expression of PNPLA2 protein CTD PMID:34186270 bisphenol F increases expression ISO RGD:1354502 6480464 bisphenol F results in increased expression of PNPLA2 protein CTD PMID:34186270 buspirone increases expression ISO RGD:1309044 6480464 Buspirone results in increased expression of PNPLA2 mRNA CTD PMID:24136188 cadmium dichloride multiple interactions EXP 6480464 [MT1 gene mutant form results in increased susceptibility to Cadmium Chloride] which results in decreased expression of PNPLA2 mRNA, [MT2 gene mutant form results in increased susceptibility to Cadmium Chloride] which results in decreased expression of PNPLA2 mRNA CTD PMID:23921151 canrenoic acid multiple interactions ISO RGD:1309044 6480464 [Diethylnitrosamine co-treated with Dietary Fats co-treated with Canrenoic Acid] results in increased expression of PNPLA2 mRNA CTD PMID:30298849 carbon nanotube increases expression EXP 6480464 Nanotubes more ... CTD PMID:25554681 , PMID:25620056 carmustine increases expression ISO RGD:1309044 6480464 Carmustine results in increased expression of PNPLA2 mRNA CTD PMID:16005536 choline multiple interactions EXP 6480464 [Choline deficiency co-treated with Methionine deficiency] results in increased expression of PNPLA2 mRNA more ... CTD PMID:20938992 , PMID:25178843 chromium(6+) affects expression EXP 6480464 chromium hexavalent ion affects the expression of PNPLA2 mRNA CTD PMID:28472532 ciguatoxin CTX1B affects expression EXP 6480464 Ciguatoxins affects the expression of PNPLA2 mRNA CTD PMID:18353800 clofibrate multiple interactions EXP 6480464 [Clofibrate co-treated with Acetaminophen] affects the expression of PNPLA2 mRNA, PPARA affects the reaction [[Clofibrate co-treated with Acetaminophen] affects the expression of PNPLA2 mRNA] CTD PMID:17585979 clofibrate increases expression EXP 6480464 Clofibrate results in increased expression of PNPLA2 mRNA CTD PMID:23811191 cobalt dichloride decreases expression ISO RGD:1354502 6480464 cobaltous chloride results in decreased expression of PNPLA2 mRNA CTD PMID:22917661 colforsin daropate hydrochloride multiple interactions EXP 6480464 PNPLA2 protein affects the reaction [Colforsin results in increased phosphorylation of and results in increased activity of PRKAA1 protein] CTD PMID:18390901 copper(II) sulfate decreases expression EXP 6480464 Copper Sulfate results in decreased expression of PNPLA2 mRNA CTD PMID:18579281 cortisol decreases expression ISO RGD:1354502 6480464 Hydrocortisone results in decreased expression of PNPLA2 mRNA CTD PMID:30776459 cycloheximide multiple interactions EXP 6480464 Cycloheximide inhibits the reaction [rosiglitazone results in increased expression of PNPLA2 protein] CTD PMID:18643838 D-glucose decreases expression ISO RGD:1354502 6480464 Glucose deficiency results in decreased expression of PNPLA2 protein CTD PMID:24802182 deoxycholic acid decreases expression EXP 6480464 Deoxycholic Acid results in decreased expression of PNPLA2 mRNA CTD PMID:23911798 dexamethasone increases expression EXP 6480464 Dexamethasone results in increased expression of PNPLA2 mRNA, Dexamethasone results in increased expression of PNPLA2 protein CTD PMID:22733784 , PMID:28292967 dexamethasone multiple interactions EXP 6480464 [Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS1 protein] results in increased expression of PNPLA2 mRNA more ... CTD PMID:29288687 , PMID:34302803 dexamethasone multiple interactions ISO RGD:1354502 6480464 [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin] results in increased expression of PNPLA2 mRNA CTD PMID:28628672 dexamethasone increases expression ISO RGD:1354502 6480464 Dexamethasone results in increased expression of PNPLA2 mRNA CTD PMID:25047013 dioxygen increases expression EXP 6480464 Oxygen deficiency results in increased expression of PNPLA2 mRNA CTD PMID:23539316 diuron increases expression ISO RGD:1309044 6480464 Diuron results in increased expression of PNPLA2 mRNA CTD PMID:21551480 epoxiconazole decreases expression EXP 6480464 epoxiconazole results in decreased expression of PNPLA2 mRNA CTD PMID:35436446 ethanol multiple interactions EXP 6480464 rosiglitazone inhibits the reaction [Ethanol results in increased expression of PNPLA2 mRNA] CTD PMID:22173916 ethanol affects expression EXP 6480464 Ethanol affects the expression of PNPLA2 mRNA CTD PMID:30319688 ethanol multiple interactions ISO RGD:1309044 6480464 Scopoletin inhibits the reaction [Ethanol results in increased expression of PNPLA2 mRNA], Silymarin inhibits the reaction [Ethanol results in increased expression of PNPLA2 mRNA] CTD PMID:26115886 ethanol increases expression ISO RGD:1309044 6480464 Ethanol results in increased expression of PNPLA2 mRNA CTD PMID:26115886 ethanol increases expression EXP 6480464 Ethanol results in increased expression of PNPLA2 mRNA CTD PMID:22173916 folic acid multiple interactions EXP 6480464 [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased methylation of PNPLA2 gene CTD PMID:20938992 fructose increases expression EXP 6480464 Fructose results in increased expression of PNPLA2 protein CTD PMID:28257781 fructose decreases expression ISO RGD:1309044 6480464 Fructose results in decreased expression of PNPLA2 mRNA CTD PMID:31661889 fructose multiple interactions ISO RGD:1309044 6480464 bisphenol A promotes the reaction [Fructose results in decreased expression of PNPLA2 mRNA], Fructose promotes the reaction [bisphenol A results in decreased expression of PNPLA2 mRNA] CTD PMID:31661889 glucose decreases expression ISO RGD:1354502 6480464 Glucose deficiency results in decreased expression of PNPLA2 protein CTD PMID:24802182 indometacin multiple interactions ISO RGD:1354502 6480464 [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin] results in increased expression of PNPLA2 mRNA CTD PMID:28628672 ketamine increases expression ISO RGD:1309044 6480464 Ketamine results in increased expression of PNPLA2 mRNA CTD PMID:20080153 L-methionine multiple interactions EXP 6480464 [Choline deficiency co-treated with Methionine deficiency] results in increased expression of PNPLA2 mRNA more ... CTD PMID:20938992 , PMID:25178843 leflunomide increases expression ISO RGD:1309044 6480464 leflunomide results in increased expression of PNPLA2 mRNA CTD PMID:24136188 Licarin A multiple interactions EXP 6480464 [licarin A affects the susceptibility to [INS protein co-treated with 1-Methyl-3-isobutylxanthine co-treated with Dexamethasone]] which results in increased expression of PNPLA2 mRNA more ... CTD PMID:29288687 Licochalcone B increases expression ISO RGD:1354502 6480464 licochalcone B results in increased expression of PNPLA2 mRNA CTD PMID:33647349 methidathion decreases expression EXP 6480464 methidathion results in decreased expression of PNPLA2 mRNA CTD PMID:34813904 methotrexate increases expression ISO RGD:1309044 6480464 Methotrexate results in increased expression of PNPLA2 mRNA CTD PMID:16005536 MK-2206 multiple interactions ISO RGD:1354502 6480464 MK 2206 inhibits the reaction [PNPLA2 protein results in increased phosphorylation of AKT1 protein] CTD PMID:31476254 N-[2-(4-bromocinnamylamino)ethyl]isoquinoline-5-sulfonamide multiple interactions EXP 6480464 N-(2-(4-bromocinnamylamino)ethyl)-5-isoquinolinesulfonamide inhibits the reaction [[licarin A affects the susceptibility to [INS protein co-treated with 1-Methyl-3-isobutylxanthine co-treated with Dexamethasone]] which results in increased expression of PNPLA2 protein] CTD PMID:29288687 N-nitrosodiethylamine multiple interactions ISO RGD:1309044 6480464 [Diethylnitrosamine co-treated with Dietary Fats co-treated with Canrenoic Acid] results in increased expression of PNPLA2 mRNA CTD PMID:30298849 nefazodone increases expression ISO RGD:1309044 6480464 nefazodone results in increased expression of PNPLA2 mRNA CTD PMID:24136188 nevirapine increases expression ISO RGD:1309044 6480464 Nevirapine metabolite results in increased expression of PNPLA2 mRNA CTD PMID:23947594 nicotine decreases expression ISO RGD:1309044 6480464 Nicotine results in decreased expression of PNPLA2 mRNA CTD PMID:29155039 nicotine multiple interactions ISO RGD:1309044 6480464 [Nicotine results in increased abundance of Cotinine] which results in increased expression of PNPLA2 mRNA, [Nicotine results in increased abundance of Cotinine] which results in increased expression of PNPLA2 protein CTD PMID:29617909 nimesulide increases expression ISO RGD:1309044 6480464 nimesulide results in increased expression of PNPLA2 mRNA CTD PMID:24136188 olanzapine affects expression ISO RGD:1309044 6480464 olanzapine affects the expression of PNPLA2 mRNA CTD PMID:23226405 ozone increases expression ISO RGD:1309044 6480464 Ozone results in increased expression of PNPLA2 mRNA CTD PMID:31397875 , PMID:35737395 ozone multiple interactions EXP 6480464 [Air Pollutants results in increased abundance of [Ozone co-treated with Soot]] which results in decreased expression of PNPLA2 mRNA CTD PMID:34911549 paracetamol multiple interactions EXP 6480464 [Clofibrate co-treated with Acetaminophen] affects the expression of PNPLA2 mRNA more ... CTD PMID:17585979 , PMID:29246445 paracetamol decreases expression EXP 6480464 Acetaminophen results in decreased expression of PNPLA2 mRNA CTD PMID:29246445 paracetamol increases expression EXP 6480464 Acetaminophen results in increased expression of PNPLA2 mRNA CTD PMID:26522476 paracetamol increases expression ISO RGD:1309044 6480464 Acetaminophen results in increased expression of PNPLA2 mRNA CTD PMID:32479839 paracetamol affects expression EXP 6480464 Acetaminophen affects the expression of PNPLA2 mRNA CTD PMID:17562736 paraquat increases expression EXP 6480464 Paraquat results in increased expression of PNPLA2 mRNA CTD PMID:21463325 perfluorooctane-1-sulfonic acid multiple interactions EXP 6480464 [perfluorooctane sulfonic acid co-treated with Cellulose] results in increased expression of PNPLA2 mRNA CTD PMID:36331819 perfluorooctanoic acid increases expression EXP 6480464 perfluorooctanoic acid results in increased expression of PNPLA2 mRNA CTD PMID:34252412 permethrin increases expression EXP 6480464 Permethrin results in increased expression of PNPLA2 mRNA CTD PMID:24911977 phosphatidylcholine decreases expression EXP 6480464 Phosphatidylcholines results in decreased expression of PNPLA2 mRNA CTD PMID:23911798 pirinixic acid multiple interactions EXP 6480464 [pirinixic acid co-treated with PPARA] results in increased expression of PNPLA2 mRNA more ... CTD PMID:20813756 , PMID:25285770 pirinixic acid increases expression ISO RGD:1309044 6480464 pirinixic acid results in increased expression of PNPLA2 mRNA CTD PMID:22484513 pirinixic acid increases expression EXP 6480464 pirinixic acid results in increased expression of PNPLA2 mRNA CTD PMID:17426115 more ... potassium chromate increases expression ISO RGD:1354502 6480464 potassium chromate(VI) results in increased expression of PNPLA2 mRNA CTD PMID:22079256 potassium chromate multiple interactions ISO RGD:1354502 6480464 [potassium chromate(VI) co-treated with epigallocatechin gallate] results in increased expression of PNPLA2 mRNA CTD PMID:22079256 propiconazole decreases expression EXP 6480464 propiconazole results in decreased expression of PNPLA2 mRNA CTD PMID:21278054 quercetin multiple interactions EXP 6480464 Quercetin inhibits the reaction [Dietary Fats results in decreased expression of PNPLA2 mRNA] CTD PMID:24025686 raspberry ketone increases expression EXP 6480464 raspberry ketone results in increased expression of PNPLA2 mRNA CTD PMID:36460224 resveratrol increases expression ISO RGD:1309044 6480464 resveratrol results in increased expression of PNPLA2 protein CTD PMID:23824959 resveratrol multiple interactions ISO RGD:1354502 6480464 [Plant Extracts co-treated with Resveratrol] results in decreased expression of PNPLA2 mRNA CTD PMID:23557933 resveratrol multiple interactions EXP 6480464 PNPLA2 protein promotes the reaction [resveratrol results in decreased expression of IL6 mRNA], PNPLA2 protein promotes the reaction [resveratrol results in decreased expression of TNF mRNA] CTD PMID:24817795 resveratrol increases expression EXP 6480464 resveratrol results in increased expression of PNPLA2 mRNA, resveratrol results in increased expression of PNPLA2 protein CTD PMID:22945685 more ... resveratrol increases response to substance EXP 6480464 PNPLA2 protein results in increased susceptibility to resveratrol CTD PMID:24817795 rotenone increases expression ISO RGD:1309044 6480464 Rotenone results in increased expression of PNPLA2 mRNA CTD PMID:28374803 scopoletin multiple interactions ISO RGD:1309044 6480464 Scopoletin inhibits the reaction [Ethanol results in increased expression of PNPLA2 mRNA] CTD PMID:26115886 senecionine increases expression EXP 6480464 senecionine results in increased expression of PNPLA2 protein CTD PMID:35357534 silicon dioxide decreases expression ISO RGD:1354502 6480464 Silicon Dioxide analog results in decreased expression of PNPLA2 mRNA CTD PMID:25895662 sirolimus increases expression EXP 6480464 Sirolimus results in increased expression of PNPLA2 mRNA, Sirolimus results in increased expression of PNPLA2 protein CTD PMID:20068142 sodium arsenite decreases expression ISO RGD:1354502 6480464 sodium arsenite results in decreased expression of PNPLA2 mRNA CTD PMID:34032870 tamoxifen affects expression EXP 6480464 Tamoxifen affects the expression of PNPLA2 mRNA CTD PMID:17555576 thioacetamide increases expression ISO RGD:1309044 6480464 Thioacetamide results in increased expression of PNPLA2 mRNA CTD PMID:34492290 tioguanine increases expression ISO RGD:1309044 6480464 Thioguanine results in increased expression of PNPLA2 mRNA CTD PMID:16005536 titanium dioxide affects expression EXP 6480464 titanium dioxide affects the expression of PNPLA2 mRNA CTD PMID:23557971 tolcapone increases expression ISO RGD:1309044 6480464 tolcapone results in increased expression of PNPLA2 mRNA CTD PMID:24136188 triphenyl phosphate increases expression EXP 6480464 triphenyl phosphate results in increased expression of PNPLA2 mRNA CTD PMID:28163246 urethane increases expression ISO RGD:1354502 6480464 Urethane results in increased expression of PNPLA2 mRNA CTD PMID:28818685 valproic acid increases methylation ISO RGD:1354502 6480464 Valproic Acid results in increased methylation of PNPLA2 gene CTD PMID:29154799 valproic acid affects expression EXP 6480464 Valproic Acid affects the expression of PNPLA2 mRNA CTD PMID:17292431 , PMID:17963808 vinclozolin increases expression ISO RGD:1309044 6480464 vinclozolin results in increased expression of PNPLA2 mRNA CTD PMID:22570695 vinclozolin affects expression ISO RGD:1309044 6480464 vinclozolin affects the expression of PNPLA2 mRNA CTD PMID:19015723 vinclozolin decreases expression ISO RGD:1309044 6480464 vinclozolin results in decreased expression of PNPLA2 mRNA CTD PMID:23555832
